2018 was a ground-breaking year for orphan disease with the FDA approving a record 34 new therapies for rare populations. Clearly, the steps laid out
Pharma marketers experienced both flops and wins in 2018 – here’s how to apply these learnings to drive impact in the new year.
Transform mundane media metrics into meaningful marketing insight
Synchronize consumer and professional strategies for more effective pharma marketing